Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Innovative Skincare Clinical presents study results and product evaluations to help you assess effectiveness and safety in modern skincare.
1,173 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
The weight loss therapy wave has fireworks at the giants, but smart investors look for underrated weight loss stocks ...
As the week tightens on dividend calendars, three widely held stocks are poised to unlock their next payouts. With ex...
Healthcare costs loom large for retirees and investors alike. This article argues that one AI-driven healthcare leade...
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Abcellera's Q1 2026 earnings transcript provides key clues about the path to 2026. This guide breaks down revenue dri...
A clear, investor-friendly look at Iridex's Q1 2026 performance and what it could mean for the full year. Learn the n...
Moderna rose to fame with COVID-19 vaccines, but the road to sustained profits is more complex. This guide breaks dow...
When a company director buys a sizable stake, investors take notice. This article breaks down the meaning behind the ...
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A regulatory hint sent Moderna stock just popped, but the journey from acceptance to approval matters. This guide bre...